We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Drones to Optimize Exchange of Samples between Hospitals

By LabMedica International staff writers
Posted on 18 Apr 2017
Print article
Image: A quadrocopter drone transporting a biological safety box (Photo courtesy of Swiss Post).
Image: A quadrocopter drone transporting a biological safety box (Photo courtesy of Swiss Post).
Switzerland is slated to become one of the first countries in the world to introduce the use of drones for routine transport of medical samples between hospitals.

A recent announcement stated that Swiss Post and the drone manufacturer Matternet would provide the infrastructure to transport samples between the Ticino EOC hospital group's Ospedale Italiano and the Ospedale Civico hospitals.

The drones to be used are compact quadrocopters that can carry up to two kilograms for up to 20 kilometers at an average speed of 36 kilometers per hour. Biological samples will be carried in a dedicated safety box, and the drones will be controlled with a smartphone application.

So far around 70 autonomous test flights have been conducted between the two hospital locations. The Swiss Federal Office for Civil Aviation (FOCA) has inspected the drone and its safety components, defined the legal conditions for flying it, and granted Swiss Post and Matternet approval for the flights. Further testing with flights is planned over a one-month period in summer 2017 and regular drone flights are expected to begin in 2018.

It is planned that drones will complement traditional parcel delivery sensibly, but they will not replace it.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.